1. Mujagic Z,
Mujagic H
Importance of serum prolactin determination in metastatic breast cancer
patients
CROATIAN MEDICAL JOURNAL 45 (2): 176-180 APR 2004
Times Cited:
5
2. Mujagic Z,
Mujagic H
Circulating levels of prolactin as an indicator of effectiveness of therapy
in breast cancer patients
INTERNATIONAL JOURNAL OF CANCER : 216-216
Suppl. 13 2002
Times
Cited:
0
3. Mujagic H,
Chabner BA, Mujagic Z
Mechanisms of action and potential therapeutic uses of thalidomide
CROATIAN MEDICAL JOURNAL 43 (3): 274-285 JUN 2002
Times Cited:
4
4. MUJAGIC H,
MUJAGIC Z
DETECTION OF PLEIOTROPIC DRUG-RESISTANCE BY THE RAPID IMMUNOFLUORESCENCE
ASSAY OF DRUG EFFECTS ON THE CELL SKELETON
ONCOLOGY 48 (3): 202-209
MAY-JUN 1991
Times Cited:
4
5. MUJAGIC H,
KRNJAJIC N, JEVRIC A
THE LEVELS AND RELATIONS OF PROSTAGLANDINS IN PREGNANT AND NON-PREGNANT
TUMOR-BEARING MICE
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
115 (4): 383-387 1989
Times Cited:
0
6. MUJAGIC H,
SHACKNEY SE, SMITH CE, et al.
QUANTITATIVE CHANGES IN SURFACE-IMMUNOGLOBULIN EXPRESSION IN WEHI-231
LYMPHOMA-CELLS IN RELATION TO THEIR PROLIFERATIVE RATE
ONCOLOGY 43
(4): 237-242 1986
Times
Cited:
1
7.
MUJAGIC H, HAMEL E, CURT G, et al.
DETECTION OF PLEIOTROPIC DRUG-RESISTANCE (PDR) BY IMMUNOFLUORESCENT ASSAY OF
DRUG EFFECTS ON CYTOSKELETON
PROCEEDINGS OF THE AMERICAN ASSOCIATION
FOR CANCER RESEARCH 26 (MAR): 338-338 1985
Times Cited:
0
8. CURT GA,
BAILEY BD, MUJAGIC H, et al.
PLEIOTROPIC DRUG-RESISTANCE (PDR) IN HUMAN MCF-7 BREAST-CANCER CELLS
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 25 (MAR):
337-337 1984
Times Cited:
1
9. MALENICA B,
MUJAGIC H, POPOVIC S, et al.
IMMUNOCOMPETENCE IN PATIENTS WITH MALIGNANT-MELANOMA
PERIODICUM
BIOLOGORUM 85: 351-352 Suppl. 3 1983
Times Cited:
0
10. MUJAGIC H,
OCCHIPINTI S, SMITH C, et al.
QUANTITATIVE CHANGES IN SURFACE-IMMUNOGLOBULIN IN RELATION TO
CELL-PROLIFERATION IN MURINE WEHI-231 B-CELL LYMPHOMA INVITRO
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 24 (MAR): 7-7
1983
Times Cited:
0
11. MUJAGIC H,
CHEN SS, GEIST R, et al.
EFFECTS OF VINCRISTINE ON CELL-SURVIVAL, CELL-CYCLE PROGRESSION, AND MITOTIC
ACCUMULATION IN ASYNCHRONOUSLY GROWING SARCOMA 180-CELLS
CANCER
RESEARCH 43 (8): 3591-3597 1983
Times Cited:
20
12. MUJAGIC H,
CONGER BM, SMITH CA, et al.
SCHEDULE DEPENDENCE OF VINCRISTINE LETHALITY IN SARCOMA 180 CELLS FOLLOWING
PARTIAL SYNCHRONIZATION WITH HYDROXYUREA
CANCER RESEARCH 43 (8):
3598-3603 1983
Times
Cited:
3
13. CONGER B,
OCCHIPINTI SJ, MUJAGIC H, et al.
STUDIES ON THE LETHAL AND SUBLETHAL EFFECTS OF VINCRISTINE (VCR) IN SARCOMA
180 INVITRO
CELL AND TISSUE KINETICS 15 (6): 674-674 1982
Times Cited:
0
14. MUJAGIC H,
SMITH CE, SCHUETTE WH, et al.
THE CELL TUBULIN CONTENT FREQUENCY HISTOGRAM OBTAINED BY FLOW-CYTOMETRY IN
SARCOMA 180 CELLS-INVITRO
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR
CANCER RESEARCH 23 (MAR): 28-28 1982
Times Cited:
1
15. MUJAGIC H
IMMUNOTHERAPY WITH BCG - AN ATTEMPT AT STANDARDIZATION OF METHODS BASED ON
OUR EXPERIENCE AND RESULTS
PERIODICUM BIOLOGORUM 82 (2): 195-205 1980
Times Cited:
0
16.
MUJAGIC H, DESKOVIC M, MALENICA B, et al.
THE SIGNIFICANCE OF TUBERCULIN IMMUNITY TESTING IN CANCER-PATIENTS
CELLULAR AND MOLECULAR BIOLOGY 26 (2): 111-121 1980
Times Cited:
2
17.
MUJAGIC H, KOLARIC K, MALENICA B, et al.
BCG IMMUNOTHERAPY IN PREVIOUSLY TREATED MALIGNANT-MELANOMA PATIENTS
BIOMEDICINE 30 (2): 95-102 1979
Times Cited:
2
18.
MUJAGIC H, KRUSIC J, DESKOVIC M, et al.
IMMUNOLOGICAL REACTIVITY TO NONSPECIFIC ANTIGENS IN CERVICAL CARCINOMA
PATIENTS
PERIODICUM BIOLOGORUM 78: 151-153 Suppl. 1 1976
Times
Cited:
0
19.
MUJAGIC H, NOLA P, MALENICA B, et al.
IMMUNOLOGICAL REACTIVITY IN COLORECTAL CARCINOMA PATIENTS WITH SPECIAL
REFERENCE TO NEW T-S CLASSIFICATION OF CARCINOMAS OF COLON AND RECTUM
PERIODICUM BIOLOGORUM 78: 153-154 Suppl. 1 1976
Times Cited:
1
20.ROGAN J, MUJAGIC H,
MALENICA B
LYMPHOCYTE CYTOTOXICITY TO MALIGNANT-MELANOMA AND CERVICAL CARCINOMA CELLS
PERIODICUM BIOLOGORUM 78: 155-156 Suppl. 1 1976
Times Cited:
0
21. MUJAGIC H,
MAZURAN R, MALENICA B, et al.
CLINICAL DETECTION OF CELLULAR IMMUNITY INVITRO TO MELANOMA SPECIFIC
ANTIGENS IN MAN BY MONOCYTE SPREADING INHIBITION TEST - CORRELATION BETWEEN
INVIVO AND INVITRO IMMUNOLOGICAL TEST PARAMETERS
PERIODICUM
BIOLOGORUM 78: 156-157 Suppl. 1 1976
Times Cited:
0
22.
MALENICA B, MUJAGIC H, KOLARIC K, et al.
BCG IMMUNOTHERAPY IN METASTATIC MALIGNANT-MELANOMA
PERIODICUM
BIOLOGORUM 78: 158-158 Suppl. 1 1976
Times Cited:
0
23. MAZURAN R,
MUJAGIC H, MALENICA B, et al.
INVITRO DETECTION OF CELLULAR IMMUNITY TO MELANOMA ANTIGENS IN MAN BY
MONOCYTE SPREADING INHIBITION TEST
INTERNATIONAL JOURNAL OF CANCER 17
(1): 14-20 1976
Times
Cited:
14
24. MILAS L,
MUJAGIC H
EFFECT OF SPLENECTOMY ON FIBROSARCOMA METASTASES IN LUNGS OF MICE
INTERNATIONAL JOURNAL OF CANCER 11 (1): 186-190 1973
Times Cited:
43
25. MILAS L,
MUJAGIC H
PROTECTION BY CORYNEBACTERIUM PARVUM AGAINST TUMOR-CELLS INJECTED
INTRAVENOUSLY
REVUE EUROPEENNE D ETUDES CLINIQUES ET BIOLOGIQUE 17
(5): 498& 1972
Times
Cited:
3
